Ongoing R&D projects targeting bacteria as of 2021, by pharmaceutical company
Among the major pharmaceutical companies, there were 86 ongoing R&D projects to develop medicines and vaccines targeting bacteria in 2021. GSK was the pharmaceutical company with most ongoing R&D projects targeting bacteria, with 15 antibacterial vaccines and 15 antibacterial medicines in different phases of the R&D pipeline. This statistic displays the number of ongoing R&D projects targeting bacteria as of 2021, by pharmaceutical company.